 |
市场调查报告书
商品编码
1181767
利多卡因软膏市场：按配方、年龄组、应用、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
外用利多卡因软膏用于身体的各个部位，使正在接受某些医疗程序（例如手术）的患者麻木。 它还用于缓解由晒伤、常春籐、漆树和轻微割伤和擦伤等情况引起的疼痛和瘙痒。 它也被男性和女性用于预防和控制尿道手术期间的疼痛。
利多卡因通常用作局部麻醉剂，但也用作抗心律失常剂、镇痛剂和气管插管的辅助剂。 它是 Vaughan-Williams 分类中的叔胺，是一种抗心律失常药。 利多卡因在麻醉学、心脏病学和疼痛管理中是一种有价值的工具。 在血浆中，利多卡因有 65% 的蛋白质与白蛋白和 α-1 酸性糖蛋白结合，与其他局部麻醉剂相比具有中等的作用持续时间。 利多卡因软膏用于在某些医疗/牙科手术之前麻醉口腔和喉咙的内层。
市场动态
市场主要参与者为扩大产品而进行的利多卡因软膏研发活动的增加预计将在预测期内推动市场增长。 例如，2021 年 1 月，亚利桑那州的梅奥诊所开始了一项临床研究，比较两种局部麻醉剂对面部点阵非烧蚀激光治疗的效果。 2.5g 利多卡因 23%/丁卡因 7% 软膏正在进行 2 期临床试验，7.5g 利多卡因 2.5%/丙胺卡因 2.5% 乳膏正在进行 3 期临床试验。 预计完工日期为 2023 年 1 月。
这项研究的主要特点
- 本报告对全球利多卡因软膏市场进行了深入分析，展示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。.
- 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
- 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
- 根据公司亮点、产品组合、主要亮点、绩效和战略等参数对全球利多卡因软膏市场的主要参与者进行了概况分析。
- 本研究涉及的主要公司包括 Glenmark Pharmaceuticals U.S. Inc.、Teligent Inc.、Taro Pharmaceutical Industries Ltd.、CENTURA PHARMACEUTICALS INC.、Neon Laboratories Ltd.、ASTRAZENECA CANADA INC.、Novocol Pharma 和 Amneal Pharmaceuticals LLC。 、Alembic Pharmaceuticals Limited、Ascend Laboratories LLC、Liberty Pharmaceuticals, Inc.、Hi-Tech Pharmaceuticals、Aspen Pharmacare Australia Pty Ltd.、Sandoz AG、Zydus Healthcare Limited.、Quagen Pharmaceuticals、Zuche Pharmaceuticals Private Limited. 和 SEPTO DONT, Inc.
- 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
- 全球利多卡因软膏市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以通过用于分析全球利多卡因软膏市场的各种战略矩阵来促进他们的决策。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写说明
第二章市场展望
- 报告内容
- 市场定义和范围
- 执行摘要
- 市场概况：按配方分类
- 市场概况：按年龄组
- 市场概况：按应用分类
- 市场概况：按分销渠道
- 市场概况：按地区
- 连贯机会图 (COM)
第3章市场动态、规律及趋势分析
- 市场动态
- 司机
- 约束因素
- 市场吸引力分析
- 市场机会
- 产品发布
- 合併、收购、联合研究
- 管道分析
- 监管准则和合规性
- 政府干预
- 害虫分析
- 技术
- 品牌属性映射
- 投资活动
第 4 章利多卡因软膏的全球市场-冠状病毒 (COVID-19) 大流行的影响
- 经济影响
- COVID-19 的流行病学特征
- 政府举措
第 5 章全球利多卡因软膏市场：按配方分类，2017-2030
- 内部使用
- 专题
第 6 章全球利多卡因软膏市场：按年龄组划分，2017-2030
- 儿科
- 成人
第 7 章全球利多卡因软膏市场应用，2017-2030
- 昆虫叮咬
- 晒伤
- 小裁员
- 口腔炎
- 其他
第 8 章。全球利多卡因软膏市场：按分销渠道，2017-2030 年（百万美元
- 医院药房
- 零售药房
- 在线药店
第 9 章按地区分列的全球利多卡因软膏市场，2017-2030
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第10章竞争格局
- Glenmark Pharmaceuticals U.S. Inc.
- Teligent Inc.
- Taro Pharmaceutical Industries Ltd.
- CENTURA PHARMACEUTICALS INC.
- Neon Laboratories Ltd
- ASTRAZENECA CANADA INC.
- Novocol Pharma
- Amneal Pharmaceuticals LLC
- Alembic Pharmaceuticals Limited
- Ascend Laboratories LLC
- Liberty Pharmaceuticals, Inc.
- Hi-Tech Pharmaceuticals
- Aspen Pharmacare Australia Pty Ltd.
- Sandoz AG
- Zydus Healthcare Limited
- Quagen Pharmaceuticals
- Zuche Pharmaceuticals Private Limited.
- SEPTODONT, Inc.
第 11 章章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5434
Topical lidocaine ointment is used on various parts of the body to cause loss of sensation in patients undergoing certain medical procedures, such as surgery. It is also used to relieve pain and itching caused by conditions such as sun burn, poison ivy, poison oak, minor cuts and abrasions. It is also used to prevent and control pain during urethral surgery in both men and women.
Lidocaine is a local anesthetic commonly used for local anesthesia, but it is also used as an antiarrhythmic and analgesic drug and also used as an adjutant to endotracheal intubation. It is a tertiary amine and an antiarrhythmic drug according to the Vaughan-Williams classification. Lidocaine acts as a valuable tool in anesthesiology, cardiology, and pain management. In plasma, lidocaine has 65% of its protein bound to albumin and alpha 1 acid glycoprotein, giving it an intermediate duration of action compared to other local anesthetics. Lidocaine ointment are used to numb the lining of the mouth or throat before certain medical/dental procedures.
Market Dynamics
The increasing research and development activities of lidocaine ointment for product expansion by the key players in the market, which is expected to drive the market growth over the forecast period. For instance, in January 2021, The Mayo Clinic in Arizona has initiated a clinical study comparing two local anesthetics for fractional non-ablative laser treatment of the face. 2.5 g lidocaine 23%/tetracaine 7% ointment is in Phase 2 and 7.5 g lidocaine 2.5%/prilocaine 2.5% cream is in Phase 3 clinical trials. The scheduled completion date is January 2023.
Key features of the study:
- This report provides an in-depth analysis of the global lidocaine ointment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lidocaine ointment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Glenmark Pharmaceuticals U.S. Inc., Teligent Inc., Taro Pharmaceutical Industries Ltd., CENTURA PHARMACEUTICALS INC., Neon Laboratories Ltd., ASTRAZENECA CANADA INC., Novocol Pharma, Amneal Pharmaceuticals LLC., Alembic Pharmaceuticals Limited, Ascend Laboratories LLC, Liberty Pharmaceuticals, Inc., Hi-Tech Pharmaceuticals, Aspen Pharmacare Australia Pty Ltd., Sandoz AG, Zydus Healthcare Limited., Quagen Pharmaceuticals, Zuche Pharmaceuticals Private Limited., and SEPTODONT, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lidocaine ointment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lidocaine ointment market
Detailed Segmentation:
- Global Lidocaine Ointment Market, By Formulation:
- Internal Use
- Topical Use
- Global Lidocaine Ointment Market, By Age Group:
- Children
- Adult
- Global Lidocaine Ointment Market By Application:
- Insect Bite
- Sun Burn
- Minor Cut
- Mouth Sore
- Others
- Global Lidocaine Ointment Market By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Lidocaine Ointment Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Glenmark Pharmaceuticals U.S. Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teligent Inc
- Taro Pharmaceutical Industries Ltd.
- CENTURA PHARMACEUTICALS INC
- Neon Laboratories Ltd.
- ASTRAZENECA CANADA INC
- Novocol Pharma
- Amneal Pharmaceuticals LLC.
- Alembic Pharmaceuticals Limited
- Ascend Laboratories LLC
- Liberty Pharmaceuticals, Inc.
- Hi-Tech Pharmaceuticals
- Aspen Pharmacare Australia Pty Ltd.
- Sandoz AG
- Zydus Healthcare Limited.
- Quagen Pharmaceuticals
- Zuche Pharmaceuticals Private Limited.
- SEPTODONT, Inc.
- Glenmark Pharmaceuticals U.S. Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Age Group
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
- Pipeline Analysis
- Regulatory Guideline and Compliances
- Government Intervention
- PEST Analysis
- Technology Landscape
- Brand Attribute Mapping
- Investments
4. Global Lidocaine Ointment Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Government Initiatives
5. Global Lidocaine Ointment Market, By Formulation, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Internal Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Topical Use
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Lidocaine Ointment Market, By Age Group, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Lidocaine Ointment Market, By Application, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
- Insect Bite
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Sun Burn
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Minor Cut
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Mouth Sore
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Lidocaine Ointment Market, By Distribution Channel, 2017 - 2030, (US$ Million
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
9. Global Lidocaine Ointment Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Glenmark Pharmaceuticals U.S. Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teligent Inc.
- Taro Pharmaceutical Industries Ltd.
- CENTURA PHARMACEUTICALS INC.
- Neon Laboratories Ltd
- ASTRAZENECA CANADA INC.
- Novocol Pharma
- Amneal Pharmaceuticals LLC
- Alembic Pharmaceuticals Limited
- Ascend Laboratories LLC
- Liberty Pharmaceuticals, Inc.
- Hi-Tech Pharmaceuticals
- Aspen Pharmacare Australia Pty Ltd.
- Sandoz AG
- Zydus Healthcare Limited
- Quagen Pharmaceuticals
- Zuche Pharmaceuticals Private Limited.
- SEPTODONT, Inc.
11. Section
- Research Methodology
- About Us
